PRESS RELEASE published on 06/20/2023 at 07:15, 2 years 9 months ago Cosmo Pharmaceuticals announces approval of Winlevi® in Canada
PRESS RELEASE published on 05/26/2023 at 17:30, 2 years 10 months ago Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting
PRESS RELEASE published on 03/30/2023 at 07:00, 3 years ago Cosmo announces territory expansion agreement for Lumeblue™ (Methylene Blue MMX™) with China Medical System Holdings
PRESS RELEASE published on 03/23/2023 at 07:00, 3 years ago Cosmo reports record 2022 financial results exceeding guidance, increased dividend by 10%, confirms 2023 guidance
PRESS RELEASE published on 03/22/2023 at 07:00, 3 years ago Cosmo Pharmaceuticals announces that Cosmo Intelligent Medical Devices – IMD Ltd, fully owned subsidiary of Cosmo Pharmaceuticals, and Medtronic to expand cooperation on GI Genius™
PRESS RELEASE published on 03/16/2023 at 07:00, 3 years ago Invitation to Cosmo’s full-year 2022 financial results and 2023 outlook webcast presentation on 23 March 2023
PRESS RELEASE published on 02/16/2023 at 07:00, 3 years 1 month ago Cosmo Pharmaceuticals reports record results for 2022, preliminary results exceeding guidance, increased dividend distribution and 2023 guidance
Published on 04/09/2026 at 16:00, 2 hours 40 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 4 hours ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 4 hours 40 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 5 hours 10 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 5 hours 10 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 18:15, 25 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 3 hours ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 18:35, 5 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 2 hours 42 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 11 hours 40 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
